Elevated FAM3C promotes cell epithelial– mesenchymal transition and cell migration in gastric cancer

References

• van CutsemESagaertXTopalBHaustermansKPrenenHGastric cancerLancet2016388100602654266427156933
   PubMed Web of Science ®Google Scholar
• RovielloGRavelliAPolomKApatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancerCancer Lett2016372218719126797419
   PubMed Web of Science ®Google Scholar
• ChangJWangSZhangZMultiple receptor tyrosine kinase activation attenuates therapeutic efficacy of the fibroblast growth factor receptor 2 inhibitor AZD4547 in FGFR2 amplified gastric cancerOncotarget2015642009202225576915
   PubMedGoogle Scholar
• ZhuYXuGPatelACloning, expression, and initial characterization of a novel cytokine-like gene familyGenomics200280214415012160727
   PubMed Web of Science ®Google Scholar
• WaernerTAlacakaptanMTamirIILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cellsCancer Cell200610322723916959614
   PubMed Web of Science ®Google Scholar
• GaoZHLuCWangZNILEI: a novel marker for epithelial-mesenchymal transition and poor prognosis in colorectal cancerHistopathology201465452753824738665
   PubMed Web of Science ®Google Scholar
• ZhuYHZhangBLiMPrognostic significance of FAM3C in esophageal squamous cell carcinomaDiagn Pathol20151019226498278
   PubMed Web of Science ®Google Scholar
• ZhaoXLuoGFanYMaXZhouJJiangHILEI is an important intermediate participating in the formation of TGF-β1-induced renal tubular EMTCell Biochem Funct2018362465529336056
   PubMed Web of Science ®Google Scholar
• ChenZDingLYangWHepatic activation of the FAM3C-HSF1-CaM pathway attenuates hyperglycemia of obese diabetic miceDiabetes20176651185119728246289
   PubMed Web of Science ®Google Scholar
• DuanGTangQYanHA Strategy to delay the development of cisplatin resistance by maintaining a certain amount of cisplatin-sensitive cellsSci Rep20177143228348367
   PubMed Web of Science ®Google Scholar
• ShannonPMarkielAOzierOCytoscape: a software environment for integrated models of biomolecular interaction networksGenome Res200313112498250414597658
   PubMed Web of Science ®Google Scholar
• CsiszarAKutayBWirthSInterleukin-like epithelial-to-mesenchymal transition inducer activity is controlled by proteolytic processing and plasminogen-urokinase plasminogen activator receptor system-regulated secretion during breast cancer progressionBreast Cancer Res201416543325212966
   PubMed Web of Science ®Google Scholar
• WangLYLiuYPChenLGPyruvate kinase M2 plays a dual role on regulation of the EGF/EGFR signaling via E-cadherin-dependent manner in gastric cancer cellsPLoS One201386e6754223840737
   PubMed Web of Science ®Google Scholar
• LiuXLZhangXTMengJING5 knockdown enhances migration and invasion of lung cancer cells by inducing EMT via EGFR/PI3K/Akt and IL-6/STAT3 signaling pathwaysOncotarget2017833542655427628903339
   PubMedGoogle Scholar
• WangMWuHLiSSYNJ2BP promotes the degradation of PTEN through the lysosome-pathway and enhances breast tumor metastasis via PI3K/AKT/SNAI1 signalingOncotarget2017852896928970629163781
   PubMedGoogle Scholar
• LiXTengSZhangYTROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMTOncotarget2017829470524706328423362
   PubMedGoogle Scholar
• HaoNBTangBWangGZHepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasisCancer Lett20153611576625727320
   PubMed Web of Science ®Google Scholar
• AchyutBRYangLTransforming growth factor-β in the gastrointestinal and hepatic tumor microenvironmentGastroenterology201114141167117821839702
   PubMed Web of Science ®Google Scholar
• HeZDongWLiQQinCLiYSauchinone prevents TGF-β-induced EMT and metastasis in gastric cancer cellsBiomed Pharmacother201810135536129499410
   PubMed Web of Science ®Google Scholar
• BokuNHER2-positive gastric cancerGastric Cancer201417111223563986
   PubMed Web of Science ®Google Scholar
• BangYJvan CutsemEFeyereislovaATrastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialLancet2010376974268769720728210
   PubMed Web of Science ®Google Scholar
• StoneRCPastarIOjehNEpithelial-mesenchymal transition in tissue repair and fibrosisCell Tissue Res2016365349550627461257
   PubMed Web of Science ®Google Scholar
• DavisFMStewartTAThompsonEWMonteithGRTargeting EMT in cancer: opportunities for pharmacological interventionTrends Pharmacol Sci201435947948825042456
   PubMed Web of Science ®Google Scholar
• LiaoTTYangMHRevisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemnessMol Oncol201711779280428649800
   PubMed Web of Science ®Google Scholar
• YeungKTYangJEpithelial-mesenchymal transition in tumor metastasisMol Oncol2017111283928085222
   PubMed Web of Science ®Google Scholar
• KatsunoYLamouilleSDerynckRTGF-β signaling and epithelial-mesenchymal transition in cancer progressionCurr Opin Oncol2013251768423197193
   PubMed Web of Science ®Google Scholar
• KorpalMLeeESHuGKangYThe miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2J Biol Chem200828322149101491418411277
   PubMed Web of Science ®Google Scholar
• SongQShengWZhangXJiaoSLiFILEI drives epithelial to mesenchymal transition and metastatic progression in the lung cancer cell line A549Tumour Biol20143521377138224072492
   PubMedGoogle Scholar
• SunYJiaXGaoQLiuXHouLThe ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin-like EMT inducer (ILEI)IUBMB Life2017691162127862841
   PubMed Web of Science ®Google Scholar
• OsakiMOshimuraMItoHPI3K-Akt pathway: its functions and alterations in human cancerApoptosis20049666767615505410
   PubMed Web of Science ®Google Scholar